We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Gevo
GEVO
$382M
| $178K | ﹤0.01% |
232,100
-1,127,836
| -83% | -$981K |
|
2702
Harvard Bioscience
HBIO
$29.2M
| $178K | ﹤0.01% |
4,198
-1,126
| -21% | -$50.6K |
|
2703
Ocular Therapeutix
OCUL
$2.02B
| $177K | ﹤0.01% |
19,413
-91,587
| -83% | -$650K |
|
2704
Wrap Technologies
WRAP
$104M
| $176K | ﹤0.01% |
+78,092
| New | +$263K |
|
|
ETWO
2705
DELISTED
E2open Parent Holdings
ETWO
| $176K | ﹤0.01% |
+39,746
| New | +$161K |
|
|
KRON
2706
DELISTED
Kronos Bio
KRON
| $172K | ﹤0.01% |
132,320
-5,893
| -4% | -$6.72K |
|
2707
Definitive Healthcare
DH
$75.3M
| $172K | ﹤0.01% |
21,315
-31,937
| -60% | -$282K |
|
|
NCV
2708
Virtus Convertible & Income Fund
NCV
$390M
| $171K | ﹤0.01% |
+12,767
| New | +$168K |
|
|
SFIX
2709
Stitch Fix
SFIX
$560M
| $170K | ﹤0.01% |
64,310
-1,112,518
| -95% | -$3.43M |
|
|
BGFV
2710
DELISTED
Big 5 Sporting Goods
BGFV
| $168K | ﹤0.01% |
47,772
+27,294
| +133% | +$131K |
|
2711
Tilly's
TLYS
$128M
| $168K | ﹤0.01% |
24,694
+54
| +0.2% | +$394 |
|
|
ADVM
2712
DELISTED
Adverum Biotechnologies
ADVM
| $167K | ﹤0.01% |
11,842
-32,798
| -73% | -$499K |
|
|
IGMS
2713
DELISTED
IGM Biosciences
IGMS
| $167K | ﹤0.01% |
+17,335
| New | +$201K |
|
|
TRVG
2714
trivago
TRVG
$397M
| $167K | ﹤0.01% |
60,295
-11,350
| -16% | -$28.7K |
|
2715
Energy Services of America
ESOA
$292M
| $165K | ﹤0.01% |
+20,015
| New | +$147K |
|
|
LUCK
2716
Lucky Strike Entertainment
LUCK
$911M
| $164K | ﹤0.01% |
11,973
-20,902
| -64% | -$270K |
|
|
IONQ.WS
2717
IonQ Inc Warrants
IONQ.WS
$8.06B
| $164K | ﹤0.01% |
59,500
| – | – |
|
2718
Cosan
CSAN
$2.84B
| $163K | ﹤0.01% |
12,600
-20,700
| -62% | -$297K |
|
|
ORGN
2719
DELISTED
Origin Materials
ORGN
| $163K | ﹤0.01% |
10,659
+3,047
| +40% | +$52.9K |
|
2720
Capricor Therapeutics
CAPR
$237M
| $163K | ﹤0.01% |
24,000
+4,300
| +22% | +$20.8K |
|
2721
SoundThinking
SSTI
$103M
| $162K | ﹤0.01% |
+10,178
| New | +$194K |
|
2722
Ecopetrol
EC
$34.5B
| $161K | ﹤0.01% |
13,600
-104,600
| -88% | -$1.21M |
|
2723
Ambev
ABEV
$46.4B
| $161K | ﹤0.01% |
64,900
-478,100
| -88% | -$1.25M |
|
|
CLBTW
2724
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
| $160K | ﹤0.01% |
+74,500
| New | +$147K |
|
2725
Motorcar Parts of America
MPAA
$258M
| $160K | ﹤0.01% |
19,849
-17,305
| -47% | -$156K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.